Life Science Washington reported in March 2026 that Seattle’s market remains stable despite slight dips in vacancy and funding, supported by major leases from companies like SystImmune and Seattle Children’s Research Institute.
Alexandria’s 701 Dexter Crosses Toward Stabilization As Seattle Lab Demand Reawakens
Share: